550 related articles for article (PubMed ID: 25071023)
1. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
van Bloemendaal L; IJzerman RG; Ten Kulve JS; Barkhof F; Konrad RJ; Drent ML; Veltman DJ; Diamant M
Diabetes; 2014 Dec; 63(12):4186-96. PubMed ID: 25071023
[TBL] [Abstract][Full Text] [Related]
2. Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans.
van Bloemendaal L; Veltman DJ; Ten Kulve JS; Groot PF; Ruhé HG; Barkhof F; Sloan JH; Diamant M; Ijzerman RG
Diabetes Obes Metab; 2015 Sep; 17(9):878-86. PubMed ID: 26094857
[TBL] [Abstract][Full Text] [Related]
3. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes.
ten Kulve JS; Veltman DJ; van Bloemendaal L; Barkhof F; Deacon CF; Holst JJ; Konrad RJ; Sloan JH; Drent ML; Diamant M; IJzerman RG
Diabetologia; 2015 Dec; 58(12):2688-98. PubMed ID: 26385462
[TBL] [Abstract][Full Text] [Related]
4. Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation.
van Bloemendaal L; Veltman DJ; ten Kulve JS; Drent ML; Barkhof F; Diamant M; IJzerman RG
Obesity (Silver Spring); 2015 Oct; 23(10):2075-82. PubMed ID: 26331843
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus.
Bae JH; Choi HJ; Cho KIK; Kim LK; Kwon JS; Cho YM
Diabetes Metab J; 2020 Apr; 44(2):248-259. PubMed ID: 31701698
[TBL] [Abstract][Full Text] [Related]
6. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial.
Farr OM; Sofopoulos M; Tsoukas MA; Dincer F; Thakkar B; Sahin-Efe A; Filippaios A; Bowers J; Srnka A; Gavrieli A; Ko BJ; Liakou C; Kanyuch N; Tseleni-Balafouta S; Mantzoros CS
Diabetologia; 2016 May; 59(5):954-65. PubMed ID: 26831302
[TBL] [Abstract][Full Text] [Related]
7. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
[TBL] [Abstract][Full Text] [Related]
8. Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior.
Anderberg RH; Anefors C; Bergquist F; Nissbrandt H; Skibicka KP
Physiol Behav; 2014 Sep; 136():135-44. PubMed ID: 24560840
[TBL] [Abstract][Full Text] [Related]
9. The corticosteroid prednisolone increases amygdala and insula reactivity to food approach signals in healthy young men.
Serfling G; Buades-Rotger M; Harbeck B; Krämer UM; Brabant G
Psychoneuroendocrinology; 2019 Jan; 99():154-165. PubMed ID: 30245328
[TBL] [Abstract][Full Text] [Related]
10. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality.
Anderberg RH; Richard JE; Hansson C; Nissbrandt H; Bergquist F; Skibicka KP
Psychoneuroendocrinology; 2016 Mar; 65():54-66. PubMed ID: 26724568
[TBL] [Abstract][Full Text] [Related]
12. Endogenous GLP-1 alters postprandial functional connectivity between homeostatic and reward-related brain regions involved in regulation of appetite in healthy lean males: A pilotstudy.
Meyer-Gerspach AC; Ly HG; Borgwardt S; Dupont P; Beglinger C; Van Oudenhove L; Wölnerhanssen BK
Diabetes Obes Metab; 2018 Oct; 20(10):2330-2338. PubMed ID: 29790260
[TBL] [Abstract][Full Text] [Related]
13. Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide.
van Ruiten CC; Veltman DJ; Nieuwdorp M; IJzerman RG
Front Endocrinol (Lausanne); 2022; 13():863592. PubMed ID: 35600575
[TBL] [Abstract][Full Text] [Related]
14. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
Radziszewska E; Bojanowska E
Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
[TBL] [Abstract][Full Text] [Related]
16. Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.
Koska J; Sands M; Burciu C; D'Souza KM; Raravikar K; Liu J; Truran S; Franco DA; Schwartz EA; Schwenke DC; D'Alessio D; Migrino RQ; Reaven PD
Diabetes; 2015 Jul; 64(7):2624-35. PubMed ID: 25720388
[TBL] [Abstract][Full Text] [Related]
17. Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew).
Chan SW; Lin G; Yew DT; Yeung CK; Rudd JA
Neuropharmacology; 2013 Jul; 70():141-7. PubMed ID: 23357334
[TBL] [Abstract][Full Text] [Related]
18. Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study.
Farr OM; Tsoukas MA; Triantafyllou G; Dincer F; Filippaios A; Ko BJ; Mantzoros CS
Metabolism; 2016 Jul; 65(7):945-53. PubMed ID: 27282865
[TBL] [Abstract][Full Text] [Related]
19. GLP-1 receptor agonists do not affect sodium intake: Exploratory analyses from two randomized clinical trials.
Smits MM; Ten Kulve JS; van Bloemendaal L; Tonneijck L; Muskiet MHA; Kramer MHH; Ijzerman RG; van Raalte DH
Nutrition; 2019; 67-68():110524. PubMed ID: 31415908
[TBL] [Abstract][Full Text] [Related]
20. Wired for obesity?
Selvarajah D; Choudhary P; Farooqi IS
Diabetes; 2014 Dec; 63(12):4016-7. PubMed ID: 25414020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
